ClinicalTrials.gg
RecruitingNCT07787949Updated Aug 26, 2026

Injectable Platelet-Rich Fibrin With Minimally Invasive Non-Surgical Technique in Treatment of Grade II Furcation Defects

An interventional study of Minimally invasive non-surgical technique (MINST) and Minimally invasive non-surgical technique (MINST) + injectable platelet-rich fibrin (i-PRF) injection in Injectable Platelet-Rich Fibrin, Minimally Invasive and Non-Surgical Technique, sponsored by October 6 University. Recruiting at 1 site in Egypt. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-08-26.

Sponsored by October 6 University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 5 months after the study started (first participant enrolled Mar 2026, registered Aug 2026).
  • Started Mar 2026; still recruiting 8 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

This study aims to compare the clinical and radiographic effectiveness of injectable platelet-rich fibrin (i-PRF) combined with minimally invasive non-surgical therapy (MINST) versus MINST alone in the management of class II furcation defects.

Read the detailed description

Periodontitis is a multifactorial inflammatory disease that occurs due to the challenge between the host response and specific periodontal pathogens, leading to a gradual destruction of the periodontal supporting tissues over time.

Different regenerative approaches have been proposed including guided tissue regeneration (GTR); bone grafts, bioactive agents such as enamel matrix derivative (EMD) and platelet concentrates.

Using the minimally invasive nonsurgical technique (MINST) implements magnification with microscope/loupes and delicate instruments, to perform the periodontal debridement with more effective root debridement and less soft tissue trauma. MINST significantly improve the visualization and root decontamination, and at the same time preserve the gingival margin and consequently improve the aesthetic results and tissue stability.

02

Conditions studied

  • Injectable Platelet-Rich Fibrin
  • Minimally Invasive
  • Non-Surgical Technique
  • Grade II Furcation Defects

Browse trials for

03

In context

Furcation Defects

42 studies on the registry are indexed under Furcation Defects; 13 are open to participants now.

This study's planned enrollment of 30 is above the median of 27 across 38 interventional studies indexed under Furcation Defects.

Browse Furcation Defects studies →

Lead sponsor

October 6 University is the lead sponsor of 148 studies on the registry; 34 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients of both genders >18 years old, medically free of systemic diseases affecting periodontal regeneration.
  • Diagnosis of stage III, grade B periodontitis (according to the AAP/EFP classification 2018) with the presence of class II furcation defect in either the maxillary (buccal) or mandibular arch (buccal or lingual) as determined by clinical evaluation and confirmed by radiographic evaluation.
  • Gingival margin and interdental bone positioned coronally to the furcation entrance.
  • Commitment to maintenance visits and follow-up.
  • Absence of primary endodontic lesions.

Exclusion criteria

Exclusion Criteria:

  • Patients suffering from any systemic diseases that may affect the outcome of periodontal therapy, including diabetes, immune deficiencies, etc;
  • Patients that received periodontal surgical treatments in the past 12 months.
  • Smoking (current or in past 5 years)
  • Prolonged treatment with antibiotics or anti-inflammatory agents within 6 months prior to periodontal therapy.
  • Pregnant and lactating females.
  • Teeth with hopeless prognosis
  • Third molars
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
30 participants (estimated)

Study arms

  • Active comparator
    Positive control group

    Patients will receive minimally invasive non-surgical technique (MINST) alone

    Procedure: Minimally invasive non-surgical technique (MINST)

  • Experimental
    Test group

    Patients will receive minimally invasive non-surgical technique (MINST) + injectable platelet-rich fibrin (i-PRF) injection

    Procedure: Minimally invasive non-surgical technique (MINST) + injectable platelet-rich fibrin (i-PRF) injection

Interventions

  • ProcedureMinimally invasive non-surgical technique (MINST)

    Patients will receive minimally invasive non-surgical technique (MINST) alone

  • ProcedureMinimally invasive non-surgical technique (MINST) + injectable platelet-rich fibrin (i-PRF) injection

    Patients will receive minimally invasive non-surgical technique (MINST) + injectable platelet-rich fibrin (i-PRF) injection

06

What researchers measure

Primary outcomes

  1. Change in Radiographic Bone Fill at the Furcation Site

    Radiographic bone fill at the furcation site will be assessed using cone-beam computed tomography (CBCT). The analysis will include measurement of the filled bone volume (FBV) at the furcation area using segmentation.

    Time frame: 6 months after treatment

Secondary outcomes

  1. Change in Horizontal Clinical Attachment Level

    Horizontal clinical attachment level will be assessed using periodontal probing at baseline and 6 months after treatment.

    Time frame: 6 months after treatment

  2. Change in Vertical Clinical Attachment Level

    Vertical clinical attachment levels will be assessed using periodontal probing at baseline and 6 months after treatment.

    Time frame: 6 months after treatment

  3. Change in Probing Pocket Depth

    Probing pocket depth (PPD) will be measured in millimeters from the gingival margin to the base of the periodontal sulcus at six sites per tooth using a UNC-15 periodontal probe. Measurements will be recorded at baseline and 6 months after treatment.

    Time frame: 6 months after treatment

  4. Change in Gingival Margin Location

    The location of the gingival margin will be assessed by measuring the distance from the cemento-enamel junction (CEJ) to the gingival margin. Measurements will be recorded at baseline and 6 months after treatment.

    Time frame: 6 months after treatment

  5. Change in Plaque Index

    Plaque index (PI) will be assessed to evaluate oral hygiene status by measuring dental plaque accumulation in areas adjacent to the gingival margin. Plaque index will be recorded at baseline and 6 months after treatment.

    Time frame: 6 months after treatment

  6. Change in Bleeding on Probing

    Bleeding on probing (BoP) will be assessed by gently inserting a periodontal probe into the gingival sulcus at the base of the interdental papilla and recording the intensity of bleeding after a short delay. BoP will be assessed at baseline and 6 months after treatment.

    Time frame: 6 months after treatment

07

Study locations

1 of 1 sites recruiting
  • October 6 University (Faculty of Dentistry)
    Giza, Giza Governorate 12511, Egypt
    Recruiting
    • Moustafa A Ahmed, B.D.S · Contact23110295.pg@o6u.edu.eg · 00201098378998
    • Reham L Aggour, MD · Sub investigator
    • Shereen F Ahmed, MD · Sub investigator
    • Wessam I Shehab, MD · Sub investigator
08

References and documents

Individual participant data

Plan to share: Yes — The data will be available upon a reasonable request from the corresponding author after the end of study for one year.

Supporting information: Study protocol

Time frame: After the end of study for one year.

Access criteria: The data will be available upon a reasonable request from the corresponding author.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 26, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07787949
Responsible party
Moustafa Awadallah Elaref Ahmed (B.D.S Faculty of Dentistry, October 6 University, Egypt, October 6 University) — Principal investigator
First posted
Aug 26, 2026
Start date
Mar 11, 2026
Primary completion
Mar 11, 2027 (estimated)
Completion
Mar 11, 2027 (estimated)
Last update
Aug 26, 2026

Study contacts

Moustafa A Ahmed, B.D.S
Contact
23110295.pg@o6u.edu.eg
00201098378998

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion